Clinical Trial Update: Safe Accelerated Venetoclax Escalation in CLL [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting safe accelerated venetoclax escalation in chronic lymphocytic leukemia and small lymphocytic lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Venetoclax (Venclexta) (venetoclax)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING